Deciphering the role of phosphatidylinoitol 3-kinase
oncogenic mutation in conferring anti HER2 therapy resistance by enriching for the stem-like tumor initiating cell population in HER2 oncogene-positive
breast cancer
Implementing Organization
Shiv Nadar Foundation, Noida
Principal Investigator
Dr. Anindia Chakrabarty
Shiv Nadar Foundation, Noida
Project Overview
The project aims to decipher the role of phosphatidylinoitol 3-kinase oncogenic mutation in conferring anti HER2 therapy resistance by enriching for the stem-like tumor initiating cell population in HER2 oncogene-positive breast cancer.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.